Literature DB >> 8752441

[A view for understanding the pathogenesis of multiple sclerosis].

T Tabira.   

Abstract

There are 2 hypotheses for understanding the pathogenesis of multiple sclerosis (MS), viral and autoimmune ones. Although antibodies to many viruses are elevated, an MS-specific virus has not been found and none of conventional viruses has been definitely located in MS lesions. Thus, viruses, if involved, seem to be indirect. Autoimmune encephalomyelitis (EAE) has represented main aspects of MS such as inflammatory demyelinating plaques, spontaneous onset, remission and relapse. This was proven by transgenic mice that express T cell receptor genes of myelin basic protein (MBP)-specific encephalitogenic T cells (Goverman et al, 1993). The animals developed spontaneous EAE and relapsed when kept in the conventional condition. Otherwise, it was necessary to inject bacterial antigens, when they were kept in an SPF condition. We have shown that MBP89-101 specific encephalitogenic T cell clones are polyreactive (Kozovska et al, submitted). In MS, T cell responses to MBP and proteolipid protein (PLP) have been studied and certain T cell immunodominant regions are suggested. Some of the MHC-class II-restricted and MBP peptide-specific T cell clones responded to several viral antigens (Wucherpfenning and Strominger, 1995). Thus, it is highly probable that autoaggressive T cells are polyreactive and activated by viral and other antigens. I believe that this is the central mechanism operating in MS. Before reaching this conclusion, we must show that the MBP- or PLP-specific polyreactive T cells are indeed encephalitogenic. In order to prove this, we must establish an animal model, humanized mice.

Entities:  

Mesh:

Year:  1995        PMID: 8752441

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  1 in total

1.  IFNgamma production in peripheral blood of early Lyme disease patients to hLFAalphaL (aa326-345).

Authors:  Maria J C Gomes-Solecki; Gary P Wormser; Raymond J Dattwyler
Journal:  BMC Musculoskelet Disord       Date:  2002-10-17       Impact factor: 2.362

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.